abstract |
Compounds of the formula I in which R1 and X have the given meanings, their physiologically unobjectionable salts and/or solvates inhibit the binding of fibrinogen to the corresponding receptor and can be employed for the treatment of thromboses, osteoporosis, tumoural diseases, apoplexy, cardiac infarction, inflammations, arteriosclerosis and osteolytic disorders. |